BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 34469924)

  • 1. Coexistence of Sjögren's syndrome and pulmonary nodular amyloidosis.
    Tastekin F; Kerim D; Sen S; Kabasakal Y
    Int J Rheum Dis; 2023 Dec; 26(12):2563-2566. PubMed ID: 37294068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrotic or nonfibrotic interstitial lung disease in patients with primary Sjögren syndrome.
    Luppi F; Ferrara G; Faverio P
    Pol Arch Intern Med; 2023 Feb; 133(2):. PubMed ID: 36847412
    [No Abstract]   [Full Text] [Related]  

  • 3. Obinutuzumab in patients with Sjogren's disease immunised against rituximab.
    Pezot M; Nocturne G; Belkhir R; Henry J; Pavy S; Seror R; Mariette X; Bitoun S
    Ann Rheum Dis; 2024 Feb; 83(3):407-408. PubMed ID: 37945315
    [No Abstract]   [Full Text] [Related]  

  • 4. New Frontiers in Therapeutics for Interstitial Lung Diseases.
    Mesfin N; Sangani R; Shankar DA; Reardon C
    Am J Respir Crit Care Med; 2023 Apr; 207(8):1089-1091. PubMed ID: 36735934
    [No Abstract]   [Full Text] [Related]  

  • 5. Rituximab for the treatment of acute onset Interstitial Lung Disease in primary Sjogren's syndrome.
    Klinowski G; Gozzi F; Trentacosti F; Andrisani D; Sebastiani M; Clini EM
    Pulmonology; 2021; 27(6):575-578. PubMed ID: 34253493
    [No Abstract]   [Full Text] [Related]  

  • 6. Rituximab therapy in primary Sjögren's syndrome with interstitial lung disease: a retrospective cohort study.
    Chen MH; Chen CK; Chou HP; Chen MH; Tsai CY; Chang DM
    Clin Exp Rheumatol; 2016; 34(6):1077-1084. PubMed ID: 27607895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab and lupus interstitial lung disease: friend or foe?
    Efthimiou P; Kukar M; Hersh A
    Int J Rheum Dis; 2011 Feb; 14(1):e3-4. PubMed ID: 21303472
    [No Abstract]   [Full Text] [Related]  

  • 8. Dramatic reversal of lymphocytic interstitial pneumonitis in Sjögren's syndrome with rituximab.
    Swartz MA; Vivino FB
    J Clin Rheumatol; 2011 Dec; 17(8):454. PubMed ID: 22126805
    [No Abstract]   [Full Text] [Related]  

  • 9. Tocilizumab for refractory organising pneumonia associated with Sjögren's disease.
    Justet A; Ottaviani S; Dieudé P; Taillé C
    BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25976199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful Treatment of Sjogren-Associated Interstitial Lung Disease With Rituximab.
    Kesireddy N; Khokher W; Chuang J; Zink E; Syed A; Altorok N; Assaly R
    Am J Ther; 2023 Jul-Aug 01; 30(4):e388-e390. PubMed ID: 34469924
    [No Abstract]   [Full Text] [Related]  

  • 11. Pulmonary manifestations of Sjögren's syndrome.
    Flament T; Bigot A; Chaigne B; Henique H; Diot E; Marchand-Adam S
    Eur Respir Rev; 2016 Jun; 25(140):110-23. PubMed ID: 27246587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary involvement in Sjögren syndrome.
    Kokosi M; Riemer EC; Highland KB
    Clin Chest Med; 2010 Sep; 31(3):489-500. PubMed ID: 20692541
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.